Early determinants of atherosclerosis in paediatric systemic lupus erythematosus

被引:0
|
作者
Boros, C. A. [1 ,6 ,9 ]
Bradley, T. J. [2 ,9 ]
Cheung, M. M. H. [2 ,9 ]
Bargman, J. M. [5 ,7 ]
Russell, J. L. [2 ,9 ]
McCrindle, B. W. [2 ,9 ]
Adeli, K. [3 ]
Hamilton, J. [4 ,9 ]
Silverman, E. D. [1 ,6 ,8 ,9 ]
机构
[1] Hosp Sick Children, Div Rheumatol, Toronto, ON M5G 1X8, Canada
[2] Hosp Sick Children, Div Cardiol, Toronto, ON M5G 1X8, Canada
[3] Hosp Sick Children, Div Clin Biochem, Toronto, ON M5G 1X8, Canada
[4] Hosp Sick Children, Div Endocrinol, Toronto, ON M5G 1X8, Canada
[5] Toronto Gen Hosp, Div Nephrol, Toronto, ON, Canada
[6] Univ Toronto, Dept Biochem, Toronto, ON, Canada
[7] Univ Toronto, Dept Med, Toronto, ON, Canada
[8] Univ Toronto, Dept Immunol, Toronto, ON, Canada
[9] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada
关键词
vascular testing; cardiovascular risk factors; lipids; insulin resistance; LOW-DENSITY-LIPOPROTEIN; RISK-FACTORS; ACCELERATED ATHEROSCLEROSIS; MYOCARDIAL-PERFUSION; YOUNG-ADULTS; WOMEN; CHILDREN; DISEASE; HOMOCYSTEINE; PROGRESSION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To assess traditional and non-traditional cardiovascular risk factors and to determine the prevalence and correlates of early vascular markers of atherosclerosis in paediatric systemic lupus erythematosus (pSLE). Methods Fifty-four adolescents with pSLE had cardiovascular risk factor assessment, disease activity and vascular testing including carotid intima-media thickness (CIMT), flow-mediated dilatation (FMD), arterial stiffness measures, and myocardial perfusion studies. Results The traditional risk factors of hypertension, elevated triglycerides, apolipoprotein B, haemoglobin AI c and insulin levels and non-traditional risk factors of elevated homocysteine and fibrinogen were present (all p<0.001). Some arterial stiffness measures, central pulse wave velocity and characteristic impedance were elevated (p<0.001), but CIMT, FMD and myocardial perfusion were normal. Cumulative prednisone dose correlated with total cholesterol (r=0.5790, p<0.001) and elevated LDL-C (r=0.4488, p=0.0012). Hydroxychloroquine treatment correlated negatively with total cholesterol (r=-0.4867, p=0.0002), LDL-C (r=-0.4805, p=0.0002) and apolipoprotein B (r=-0.4443, p=0.0011). In multivariate analysis LDL-C correlated with cumulative prednisone dose and negatively with hydroxychloroquine treatment (R-2=0.40, p<0.001). Conclusions An increased burden of traditional and non-traditional risk factors and early evidence of insulin resistance and increased central arterial stiffness were present in paediatric SLE. Disease-specific and therapy-related factors are likely modifying these cardiovascular risk profiles warranting prospective longitudinal studies.
引用
收藏
页码:575 / 581
页数:7
相关论文
共 50 条
  • [31] Pancreatic Pseudocyst in Paediatric Systemic Lupus Erythematosus
    S. M. Al-Mayouf
    M. Majeed
    A. Al-Mehaidib
    H. Alsuhaibani
    Clinical Rheumatology, 2002, 21 : 264 - 266
  • [32] Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus
    Avalos, I.
    Rho, Y. H.
    Chung, C. P.
    Stein, C. M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (05) : S5 - S13
  • [33] Cerebral atherosclerosis in patients with systemic lupus erythematosus
    Mulic, S. O.
    Seleskovic, H. R.
    Mulic, S. O.
    Krizic, M. I.
    Zerem, E.
    Cickusic, A.
    Hajdarovic, A. R.
    Krizic, N. B.
    Seleskovic, M.
    Kusljugic, Z.
    Barakovic, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 153 - 153
  • [34] Predictors of carotid atherosclerosis in systemic lupus erythematosus
    Maksimowicz-McKinnon, Kathleen
    Magder, Laurence S.
    Petri, Michelle
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (12) : 2458 - 2463
  • [35] Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis
    Teixeira, Vitor
    Tam, Lai-Shan
    FRONTIERS IN MEDICINE, 2018, 4
  • [36] Inflammation and the pathogenesis of atherosclerosis in systemic lupus erythematosus
    McMahon, M.
    Grossman, J.
    Chen, W.
    Hahn, B. H.
    LUPUS, 2006, 15 (11) : 59 - 69
  • [37] Atherosclerosis risk factors in systemic lupus erythematosus
    Manzi S.
    Agarwal S.
    Elliott J.R.
    Current Rheumatology Reports, 2009, 11 (4) : 241 - 247
  • [38] LIPOPROTEINS AND ATHEROSCLEROSIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    DOMENECH, I
    CERVERA, R
    KHAMASHTA, MA
    MEDICINA CLINICA, 1992, 98 (19): : 749 - 752
  • [39] B cells and atherosclerosis in systemic lupus erythematosus
    Koulouri, Vasiliki
    Koutsilieris, Michael
    Mavragani, Clio P.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2019, 15 (04) : 417 - 429
  • [40] Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus
    Haque, Sahena
    Mirjafari, Hoda
    Bruce, Ian N.
    CURRENT OPINION IN LIPIDOLOGY, 2008, 19 (04) : 338 - 343